Recently, researchers in Australia tested baricitinib, a drug used for rheumatoid arthritis, in people newly diagnosed with Type‑1 diabetes, showing promising results for early intervention.

When I receive questions about pre-diabetes and Type 2 diabetes, it’s clear there is considerable confusion surrounding the underlying cause, which is insulin resistance, so let's start with some ...

The word “diabetes” serves as an umbrella term covering conditions that share a common symptom—elevated blood sugar—but diverge significantly in their underlying mechanisms, progression patterns, and ...

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

Experts say the condition—formally known as latent autoimmune diabetes in adults—can result in health complications if it isn ...

An unusual type of diabetes linked to malnutrition now has a name. Scientists are calling for wider recognition of the newly ...

Researchers at Massachusetts General Hospital (MGH), and the Broad Institute of MIT and Harvard University found gene clusters that could help explain how type 2 diabetes presents in different ...

Aug. 19, 2025 – Type 1 diabetes cases are rising faster than ever – up 42% in three decades – with sharp increases among U.S. children and teens. But new and emerging treatments are surging too, as ...

How Does Tzield Work in Type 1 Diabetes? Type 1 diabetes is an autoimmune disease in which your immune system mistakenly attacks and damages the beta cells in your pancreas. The beta cells produce ...

CHICAGO — Once-weekly semaglutide improved glycemia and reduced weight without increasing hypoglycemia in adults with type 1 diabetes (T1D) and obesity, new research presented at the American Diabetes ...